Goldman SachsGSBUYSep 11, 2024Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
He sold this a few months ago. The net-interest income pressure will challenge the money-centered banks. JPM can withstand that (he owns). For GS, the culture they once had has returned; they have strong underwriting. Volatility will raise their trading revenue in coming quarters. He likes GS and JPM among the money-centred banks. The direction of GS company is great now.